Usefulness of a placental profile in high-risk pregnancies

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 4, 2007, Pages 363.e1-363.e7

  Toal, Meghana ^a   Chan, Cynthia ^a   Fallah, Shafagh ^c   Alkazaleh, Fawaz ^a   Chaddha, Vandana ^a   Windrim, Rory C ^a   Kingdom, John C P ^a,b  

^a Maternal and Fetal Medicine Division   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

maternal serum screening; perinatal death; placental morphologic condition; placental pathologic condition; uterine artery Doppler imaging

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOPPLER FLOWMETRY; FEMALE; FETUS DEATH; HELLP SYNDROME; HIGH RISK PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; OUTCOMES RESEARCH; PERINATAL MORBIDITY; PLACENTA; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SMALL FOR DATE INFANT; UTERINE ARTERY;

EID: 34047164932     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.10.897     Document Type: Article

References (27)

1. Hypertensive disorders in pregnancy. In: Cunningham F.G., Leveno K.J., Bloom S.L., Hauth J.C., Gilstrap III L., and Wenstrom K. (Eds). Williams obstetrics. 22nd ed. (2005), McGraw-Hill, New York 761-808
2. Becher J.C., Bell J.E., Keeling J.W., Liston W.A., McIntosh N., and Wyatt B. The Scottish Perinatal Neuropathology study: clinicopathological correlation with stillbirths. BJOG 113 (2006) 310-317
3. Moldenhauer J.S., Stanek J., Warshak C., Khoury J., and Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 189 (2003) 1173-1177
4. Viero S., Chaddha V., Alkazaleh F., et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 25 (2004) 735-741
5. Chaddha V., Viero S., Huppertz B., and Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 9 (2004) 357-369
6. Ferrazzi E., Bulfamante G., Mezzopane R., Barbera A., Ghidini A., and Pardi G. Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 20 (1999) 389-394
7. Whittle W., Chaddha V., Wyatt P., Huppertz B., and Kingdom J. Ultrasound detection of placental insufficiency in women with "unexplained" abnormal maternal serum screening results. Clin Genet 69 (2006) 97-104
8. Waller D.K., Lustig L.S., Cunningham G.C., Golbus M.S., and Hook E.B. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 325 (1991) 6-10
9. LePage N., Chitayat D., Kingdom J., and Huang T. Association between second-trimester isolated high maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol 188 (2003) 1354-1359
10. Bower S., Bewley S., and Campbell S. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 82 (1993) 78-83
11. Jauniaux E., Ramsay B., and Campbell S. Ultrasonographic investigation of placental morphological characteristics and size during the second trimester of pregnancy. Am J Obstet Gynecol 170 (1994) 130-137
12. Hafner E., Metzenbauer M., Ofinger D.H., et al. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol 27 (2006) 652-657
13. Audibert F., Benchimol Y., Benattar C., Champagne C., and Frydman R. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther 20 (2005) 48-53
14. Kurdi W., Campbell S., Aquilina J., England P., and Harrington K. The role of color Doppler imaging of the uterine arteries at 20 weeks' gestation in stratifying antenatal care. Ultrasound Obstet Gynecol 12 (1998) 339-345
15. Wapner R., Thom E., Simpson J.L., et al. First trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) study group: first trimester screening for trisomies 21 and 18. N Engl J Med 350 (2004) 619-621
16. Duley L., Henderson-Smart D.J., Knight M., and King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 1 (2004) CD004659
17. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354 (1999) 810-816
18. Smith G.C., and Kingdom J.C.P. Diagnosis and management of intrauterine growth restriction. In: Kingdom J.C.P., and Baker P. (Eds). Intrauterine growth restriction (1999), Springer, London 257-274
19. American College of Obstetricians & Gynecologists. Diagnosis and management of preeclampsia and eclampsia: ACOG practice bulletin no. 33. Obstet Gynecol 99 (2002) 159-167
20. Bewley S., Chard T., Grudzinskas G., and Campbell S. The relationship of uterine and umbilical Doppler resistance to fetal and placental protein synthesis in the second trimester. Placenta 14 (1993) 663-670
21. Williams M.A., Hickok D.E., Zingheim R.W., et al. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 167 (1992) 1032-1037
22. Yu C.K., Smith G.C., Papageorghiou A.T., Cacho A.M., and Nicolaides K.H. Fetal Medicine Foundation Second Trimester Screening group: an integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193 (2005) 429-436
23. Cumberbatch C.J., Birndorf C., and Dresner N. Psychological implications of high-risk pregnancy. Int J Fertil Womens Med 50 (2005) 180-186
24. Jarvenpaa J., Pakkila M., Savolainen E.R., Perheentupa A., Jarvela I., and Ryynanen M. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in Northern Finland. Gynecol Obstet Invest 62 (2006) 28-32
25. Yu C.K., Papageorghiou A.T., Parra M., Palma D.R., and Nicolaides K.H. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 22 (2003) 233-239
26. Gris J.C., Lissalde-Lavigne G., Quere I., Dauzat M., and Mares P. Prophylaxis and treatment of thrombophilia in pregnancy. Curr Opin Hematol 13 (2006) 376-381
27. Gris J.C., Mercier E., Quere I., et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103 (2004) 3695-3699